XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Cash Flows (unaudited) - USD ($)
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash Flows From Operating Activities:    
Net loss $ (13,228,000) $ (5,162,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 219,000 52,000
Product line exit expense 747,000 0
Gain on sale of assets (11,000) 0
Warranty provision 10,000 19,000
Inventory obsolescence 0 (48,000)
Non-cash lease expense 46,000 60,000
Share-based compensation 3,007,000 1,016,000
Common shares issued for services 239,000 0
Provision for doubtful accounts 46,000 10,000
Changes in assets and liabilities:    
Accounts receivable (798,000) (307,000)
Inventories (713,000) 206,000
Prepaid expenses and other current assets (65,000) (29,000)
Accounts payable 48,000 376,000
Operating lease liability (48,000) (62,000)
Customer deposits 8,000 (193,000)
Accrued liabilities and other 53,000 165,000
Warranty settlement 16,000 0
Deferred revenue 170,000 0
Net cash used in operating activities (10,254,000) (3,897,000)
Cash Flows From Investing Activities:    
Purchase of short-term investments (25,009,000) 0
Proceeds from maturities of short-term investments 20,000,000 0
Capital expenditures for property and equipment (367,000) (69,000)
Investment in patents and trademarks (96,000) (82,000)
Proceeds from long-term deposits 3,000 0
Net cash used in investing activities (5,469,000) (151,000)
Cash Flows From Financing Activities:    
Sale of common stock and warrants 0 12,400,000
Offering costs paid on sale of common stock and warrants 0 (733,000)
Proceeds from exercise of warrants 12,048,000 10,251,000
Offering costs paid on exercise of warrants 0 (398,000)
Proceeds from exercise of stock options 278,000 515,000
Proceeds from bank note 0 414,000
Repayment of debt (200,000) 0
Net cash provided by financing activities 12,126,000 22,449,000
Net increase (decrease) in cash and cash equivalents (3,597,000) 18,401,000
Cash and cash equivalents, beginning of period 16,647,000 16,984,000
Cash and cash equivalents, end of period 13,050,000 35,385,000
Supplemental Disclosure of Non-Cash Investing and Financing Activities:    
Change in unrealized gain on short-term investments $ (2,000) $ 0